Participants in a 68-week clinical trial lost an average of 15% of their body weight compared to those who received a placebo, making Semaglutide a game-changer for weight management
(Lausanne) 12 , 678055 (2021)
Here are the ones the plotter prevents
They had a body mass index (BMI) of at least 30 on the date of treatment initiation or during the latest available primary care visit, or a BMI of at least 27 with one or more weight-related comorbidities such as hypertension, dyslipidemia, obstructive sleep apnea or cardiovascular disease
Several clinical studies have shown that chronic treatment with liraglutide delays gastric emptying [10, 19, 39]
Degenerative joint disease, osteoarthritis and overweight all go hand in hand